GenoLogics has received this award based on successfully addressing the systems biology market with an innovative solution for data management and scientific analysis
GenoLogics Life Sciences Software (GenoLogics) says it is proud to have been honoured with Frost and Sullivan's 2005 Drug Discovery Technologies Niche Player of the Year Award for its success in the systems biology market for the fiscal year 2004.
GenoLogics has received this award based on successfully addressing the systems biology market with an innovative solution for data management and scientific analysis.
The award was presented to GenoLogics on 9 November 2005 at the Frost and Sullivan 2005 Excellence in Pharmaceuticals and Life Sciences Awards Banquet in Miami, Florida.
Michael Ball, CEO of GenoLogics commented: "We are particularly pleased to receive this prestigious award from Frost and Sullivan and to be recognised for our achievements.
"We have had exceptional growth over the last year, thanks to the strong partner relationships we have with our growing roster of prominent customers and the dedication and talent of our employees who have brought new and innovative product solutions to market at a rapid pace.
"This award distinguishes GenoLogics from other companies in the market and we look forward to continued growth in 2006 in the systems biology market as we bring new products to market".
The Niche Player of the Year Award is presented to a company that has a track record of excellence in its market niche and demonstrated business and marketing strategies that ensure market success.
Frost and Sullivan conducts in depth research and analysis into companies in the field combined with interviews of market participants in order to gauge the success of a company within its niche.
Other elements considered include the company's position within the specific segment, its ability to compete against multi-segment players, and company growth during the base year.
